CAM
PFE icon

Clark Asset Management’s Pfizer PFE Stock Holding History

Clark Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$279K Sell
11,590
-2,045
-15% -$53.5K 0.02% 228
2026
Q1 		$383K Sell
13,635
-90
-0.7% -$2.4K 0.04% 151
2025
Q4 		$342K Sell
13,725
-252
-2% -$6.36K 0.04% 157
2025
Q3 		$356K Buy
13,977
+4,855
+53% +$120K 0.04% 139
2025
Q2 		$221K Buy
+9,122
New +$213K 0.03% 180

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Clark Asset Management's PFE Position: Q2 2026 in Review

Clark Asset Management reduced its Pfizer (PFE) stake by 15% in Q2 2026, selling an estimated $53.5K and leaving 11,590 shares worth $279K. The position accounts for 0.02% of the portfolio, ranked #228.

Clark Asset Management first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $383K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Clark Asset Management held 11,590 shares of Pfizer worth $279K as of Q2 2026.
  • Clark Asset Management sold 2,045 Pfizer shares in Q2 2026, an estimated $53.5K.
  • Pfizer made up 0.02% of Clark Asset Management's portfolio in Q2 2026, its #228 holding.
  • Clark Asset Management first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
  • Clark Asset Management's Pfizer position peaked at $383K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Clark Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.